We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
198 hedge funds and large institutions have $348M invested in Rocket Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 80 increasing their positions, 53 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
284% more call options, than puts
Call options by funds: $2.19M | Put options by funds: $570K
51% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 53
47% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 32
8% more capital invested
Capital invested by funds: $323M → $348M (+$25M)
6% more funds holding
Funds holding: 186 → 198 (+12)
4.69% more ownership
Funds ownership: 84.36% → 89.05% (+4.7%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
198
Holders Change
+12
Holders Change %
+6.45%
% of All Funds
2.44%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
47
Increased
80
Reduced
53
Closed
32
Calls
$2.19M
Puts
$570K
Net Calls
+$1.62M
Net Calls Change
+$1.48M
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
+$12M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$11.8M |
| 3 |
State Street
Boston,
Massachusetts
|
+$11.1M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$9.41M |
| 5 |
Millennium Management
New York
|
+$5.3M |
Top Sellers
| 1 |
SCM
Suvretta Capital Management
New York
|
-$10.5M |
| 2 |
Morgan Stanley
New York
|
-$7.64M |
| 3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$5.57M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.17M |
| 5 |
Two Sigma Investments
New York
|
-$4.11M |
